Know Cancer

or
forgot password

Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population


N/A
60 Years
74 Years
Not Enrolling
Both
Cancer

Thank you

Trial Information

Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population


Inclusion Criteria:



- WHO performance status 0 or 1

- No active liver- or kidney disease (Serum ALAT (alanine aminotransferase), alkalic
phosphatase, bilirubin, creatinin or urea within 2 S.D of laboratory reference range)

- No previous cancer diagnosis

- No known HIV-infection

- Participant must understand oral and written information

- Participant must not use selenium supplementation of above 50 mcg/d

- Participant must give written consent prior to inclusion

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention

Outcome Measure:

Viability of full scale study

Outcome Description:

At five years intervention (last participant last visit was june 2004) viability of full scale study was assessed according to the drop out rate, cost etc. of this pilot study.

Outcome Time Frame:

At five years intervention

Safety Issue:

No

Authority:

Denmark: Danish Health and Medicines Authority

Study ID:

OUH-DK-PILOT-PRECISE

NCT ID:

NCT01819649

Start Date:

November 1998

Completion Date:

June 2004

Related Keywords:

  • Cancer
  • selenium
  • selenium supplementation
  • randomised controlled trial
  • prevention

Name

Location